» Articles » PMID: 17320831

Tau and Saitohin Gene Expression Pattern in Progressive Supranuclear Palsy

Overview
Journal Brain Res
Specialty Neurology
Date 2007 Feb 27
PMID 17320831
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Deregulation of tau mRNA splicing may contribute to causing progressive supranuclear palsy (PSP). The inclusion of exon 10 produces tau protein isoforms containing all four microtubule-binding repeats (4R). Its exclusion gives rise to isoforms with three microtubule-binding repeats (3R). Alternative splicing of exons 2 and 3 produces the 0N, 1N or 2N protein isoforms. Saitohin (STH) is a nested gene included in intron 9 of tau. It has an unknown function, but could also be involved in the pathological process associated with PSP. We used real-time PCR to investigate the level of expression of tau mRNA isoforms and STH mRNA in the frontal cortex and globus pallidus of PSP patients' brains. mRNA levels were compared with those in the brains of two controls groups: healthy controls and Alzheimer's disease patients (AD). The 4R/3R mRNA ratio was significantly higher in the globus pallidus of PSP patients than in controls. The 0N mRNA isoform levels were statistically higher in the frontal cortex and globus pallidus of AD patients and were borderline higher in the globus pallidus of PSP patients than controls. In addition, when all samples were taken into account (PSP+AD+controls), a significant correlation was found between the 4R/3R mRNA tau ratio and STH expression. This correlation was stronger in the globus pallidus than in the frontal cortex. Our results suggest that abnormalities in the alternative splicing of the tau gene are involved in the molecular mechanism related to PSP pathogenesis. Such abnormalities cause an increase in the 4R/3R ratio and may lead to an overexpression of 0N tau isoforms.

Citing Articles

Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.

Zhang C, Zhu J, Wan Y, Tan L, Wang H, Yu J Oncotarget. 2017; 8(27):44994-45007.

PMID: 28402959 PMC: 5546535. DOI: 10.18632/oncotarget.16690.


Association of rs62063857 variant of the saitohin gene with Parkinson's disease.

Sonmez E, Ozel M, Islek E, Sazci A, Idrisoglu H Cell Mol Neurobiol. 2014; 35(1):115-21.

PMID: 25168738 PMC: 11486326. DOI: 10.1007/s10571-014-0102-5.


The neurogenetics of atypical parkinsonian disorders.

Fogel B, Clark M, Geschwind D Semin Neurol. 2014; 34(2):217-24.

PMID: 24963681 PMC: 4305275. DOI: 10.1055/s-0034-1381738.


Variation in tau isoform expression in different brain regions and disease states.

Majounie E, Cross W, Newsway V, Dillman A, Vandrovcova J, Morris C Neurobiol Aging. 2013; 34(7):1922.e7-1922.e12.

PMID: 23428180 PMC: 3642280. DOI: 10.1016/j.neurobiolaging.2013.01.017.


Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.

Tobin J, Latourelle J, Lew M, Klein C, Suchowersky O, Shill H Neurology. 2008; 71(1):28-34.

PMID: 18509094 PMC: 2654275. DOI: 10.1212/01.wnl.0000304051.01650.23.